Table 2 Comparison of the characteristics of non-alcoholic fatty liver disease patients who continued and discontinued their follow-up exams after a liver biopsy.
| Â | Patients who maintained their follow-up exams (n = 68) | Patients who discontinued their follow-up exams (n = 67) | p-value |
|---|---|---|---|
Age (years: mean ± S.D.) | 52.6 ± 13.4 | 44.9 ± 15.2 | 0.0035 |
Sex (male/female) (%) | 42 (61.8)/26 (38.2) | 42 (62.7)/25 (37.3) | 0.9120 |
AST (IU/L: mean ± S.D.) | 59.6 ± 35.0 | 56.4 ± 49.4 | 0.1208 |
ALT (IU/L: mean ± S.D.) | 93.6 ± 70.5 | 95.9 ± 65.4 | 0.5928 |
Medication (yes/no) (%) | 21 (30.9)/47 (69.4) | 18 (26.9)/49 (73.1) | 0.7442 |
Pathologic diagnosis (NASH/simple steatosis) (%) | 47 (69.1)/21 (30.9) | 43 (64.2)/24 (35.8) | 0.6691 |